Russell Investments Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.7M Buy
142,987
+62,292
+77% +$16.5M 0.06% 310
2026
Q1
$8.73M Buy
80,695
+9,816
+14% +$1.4M 0.01% 1021
2025
Q4
$11.8M Buy
70,879
+12,005
+20% +$2.01M 0.01% 826
2025
Q3
$11.6M Buy
58,874
+55,335
+1,564% +$9.1M 0.01% 837
2025
Q2
$320K Buy
3,539
+32
+0.9% +$2.53K ﹤0.01% 2498
2025
Q1
$209K Sell
3,507
-7,929
-69% -$733K ﹤0.01% 2578
2024
Q4
$1.52M Buy
11,436
+11,402
+33,535% +$1.07M ﹤0.01% 1797
2024
Q3
$1.78K Buy
+34
New +$1.6K ﹤0.01% 3394

Other funds holding ALAB

Russell Investments Group's ALAB Position: Q2 2026 in Review

Russell Investments Group increased its Astera Labs (ALAB) stake by 77% in Q2 2026, buying an estimated $16.5M and bringing the position to 142,987 shares worth $68.7M. The position accounts for 0.06% of the portfolio, ranked #310.

Russell Investments Group first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Russell Investments Group held 142,987 shares of Astera Labs worth $68.7M as of Q2 2026.
  • Russell Investments Group bought 62,292 Astera Labs shares in Q2 2026, an estimated $16.5M.
  • Astera Labs made up 0.06% of Russell Investments Group's portfolio in Q2 2026, its #310 holding.
  • Russell Investments Group first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.